The clinical and renal consequences of contrast-induced nephropathy.
about
Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategiesSildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injuryMultivessel Revascularization Does Not Increase Contrast-Induced Acute Kidney Injury Incidence in Acute Myocardial Infarction: A Meta-Analysis.Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registryThe Efficacy of Hydration with Normal Saline Versus Hydration with Sodium Bicarbonate in the Prevention of Contrast-induced NephropathyAcute kidney injury after using contrast during cardiac catheterization in children with heart diseaseDendrimers in medical nanotechnologyImpact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial.Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.Magnolin protects against contrast-induced nephropathy in rats via antioxidation and antiapoptosis.Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort studyTranslational toxicology and the work of the predictive safety testing consortium.Renalase protects against contrast-induced nephropathy in Sprague-Dawley rats.Association between Platelet-to-Lymphocyte Ratio and Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomographyThe role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy.Serum hyperchloremia as a risk factor for acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionContrast-induced nephropathy--a review of current literature and guidelines.Contrast-induced nephropathy following angiography and cardiac interventionsHow do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborativeContrast safety in the cancer patient: preventing contrast-induced nephropathy.Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study.Incidence and In-Hospital Mortality of Acute Kidney Injury (AKI) and Dialysis-Requiring AKI (AKI-D) After Cardiac Catheterization in the National Inpatient Sample.Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction.Asialoerythropoietin prevents contrast-induced nephropathyContrast-Induced Acute Kidney Injury: An Update.Cannabinoid receptors as therapeutic targets for dialysis-induced peritoneal fibrosis.The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia.Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice.Comparison of serum creatinine and spot urine interleukin-18 levels following radiocontrast administration.Expression of neutrophil gelatinase-associated lipocalin in low osmolar contrast-induced nephropathy in rats and the effect of N-acetylcysteineImpact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization.An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease.Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administration.Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.Bilirubin Levels are Associated With Contrast-Induced Nephropathy in Peripheral Artery Disease.Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
P2860
Q27021421-9FD35769-D68F-4EAD-BB38-5EA552A78317Q28545221-FB949FB1-985F-4EED-B624-482A53C20CA6Q30248222-F611F27C-2E2F-4E21-B439-A11291821922Q34005294-511E65E2-3388-408D-B25F-CD8E50385BE6Q34013959-0217857B-A9F4-457D-B120-2FFF97FB0590Q34029969-43370DB4-DBEE-4732-B201-F9B10E72119CQ34369684-07F52395-C090-42A1-AA02-5181B220C7D1Q34400562-00457783-2E99-4427-93C0-DE6F10EB9B45Q34453548-E10AABEB-0EA3-4116-BE86-1C9FE37AC143Q34460965-78B7D6D9-69E2-4415-B6A5-BD479A363574Q34816125-19E8BCD2-BA3B-4487-ADCC-8F436DAA2ADFQ34926489-C0E23101-E8A0-4742-BC9A-9CBE3E0B620CQ35551922-D80B114B-D7FD-4140-962C-0A5F54C93C42Q35592454-637AC710-8CDA-4756-AACD-E44D84CA9DE3Q35626471-72CF21A8-9FCE-403A-844B-64515983B8AAQ36106130-9C7ED28E-2981-4ADE-97CD-1FF4CAB321EDQ36368496-706649E6-4EAC-47E3-B8BD-FD7FED554827Q36576632-41495BAA-7927-413A-B312-C3CC639E2921Q36761998-266D01E6-6C5B-43BC-922E-82CDAF6D0590Q36915662-C6C7BF12-6BEE-4E04-8BA2-2DF7E5F0B013Q36971717-321368E8-8705-46ED-91BC-305F9947754EQ36984658-A09E3F06-3370-4C4B-B4BC-CA379D19E06FQ37090745-6022AF3E-CB53-4298-884F-1A1AD930595DQ37219177-BDD21E67-EA2B-4AAA-86CD-AF14CF9957E4Q37413246-9B4355ED-7327-42ED-B1DF-93AA4B9992BEQ38624703-29CFB387-D1E8-445F-AD18-0B07D7BD58FEQ38701320-14893379-7357-49D2-88EC-1A77B9DC69A0Q39215034-8D034618-711C-444F-A9DA-EA5AFAE5EE6DQ39404375-CB9F59B0-9A9E-4F44-8687-33FA7D0FD9DAQ40683122-5F9F5249-65F2-4E2B-B617-91E43F6FD86AQ41819920-EE61B3B6-5B31-474F-BC74-D1639D6C2CEDQ41860005-14DAAA3B-EA71-4748-AAC3-2C526F220B3BQ42858592-D729F269-8457-443C-A75A-E2949FBF8335Q43430113-55F6D76A-8031-41C2-B1E7-A261B55256DEQ44279002-99723304-D16A-4D7D-8C99-CE168A9247E7Q44305776-6BB72940-B2E1-43B1-9DE3-5DF2B8222FA4Q48086175-3A8FE91D-2C28-4166-868D-27B847939E8FQ48787719-C3AAE624-3907-4D2B-9656-AC38A139E71BQ50223910-3A071D9C-99F1-4B92-9E5C-0C6705CA5E1FQ50471223-F2AF4400-878F-495C-8923-30ED23EFED22
P2860
The clinical and renal consequences of contrast-induced nephropathy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The clinical and renal consequences of contrast-induced nephropathy.
@ast
The clinical and renal consequences of contrast-induced nephropathy.
@en
type
label
The clinical and renal consequences of contrast-induced nephropathy.
@ast
The clinical and renal consequences of contrast-induced nephropathy.
@en
prefLabel
The clinical and renal consequences of contrast-induced nephropathy.
@ast
The clinical and renal consequences of contrast-induced nephropathy.
@en
P356
P1476
The clinical and renal consequences of contrast-induced nephropathy.
@en
P2093
William F Finn
P356
10.1093/NDT/GFL213
P407
P577
2006-06-01T00:00:00Z